Clinical Trials Browser

Recruiting × Borderline Resectable Pancreatic Adenocarcinoma × Gastrointestinal × Clear all

NCT07240766 2026-02-13

HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation

Phase 2 Recruiting

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma

NCT07080021 2025-07-29

MRD

Gastrointestinal

Borderline Resectable Pancreatic Adenocarcinoma